Paclitaxel plus estramustine in metastatic hormone-refractory prostate cancer.
Year: 1995
Type: article
Study design: Clinical Trial
Source: PubMed
Authors: G R Hudes, F E Nathan, C Khater, R Greenberg, L Gomella, C Stern, C McAleer
Institution: Fox Chase Cancer Center
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: closed
Funder: National Cancer Institute
OpenAlex ID: W2410793444
